Failure of HIV-exposed CD4+ T cells to activate dendritic cells is reversed by restoration of CD40/CD154 interactions

被引:31
作者
Zhang, R
Lifson, JD
Chougnet, C
机构
[1] Cincinnati Childrens Hosp, Ctr Med, Div Mol Immunol MLC 7021, Cincinnati, OH 45229 USA
[2] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA
[3] SAIC Frederick, AIDS Vaccine Program, NCI, Frederick, MD USA
关键词
D O I
10.1182/blood-2005-07-2731
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Because interactions between activated CD4(+) T cells and antigen-presenting cells (APCs) are crucial for optimal APC function, defective CD4+ T-cell activation may contribute to APC dysregulation in HIV infection. Here, we show that CD4+ T cells exposed during stimulation to noninfectious HIV having functional envelope glycoproteins failed to provide activation signals to autologous dendritic cells (DCs). Consequently, important DC functions, including production of immunoregulatory cytokines (interleukin-12 p40 and interleukin-10) and up-regulation of costimulatory molecules (CD86, CD40, CD83), as well as the capacity to stimulate naive allogeneic T cells, were all adversely affected. The blunted upregulation of CD154 in CD4(+) T cells that were activated in the presence of noninfectious viruses is likely to be the major underlying mechanism for these defects. Addition of recombinant trimeric CD154 could restore production of cytokines by DCs cocultured with HIV-exposed T cells. Moreover, the functional defects mediated by coculture with HIV-exposed T cells were similar to those following antibody blockade of CD40-CD154 interactions. HIV-mediated blunted CD154 expression may thus play an important role in the suppression of cell-mediated immunity seen in HIV infection.
引用
收藏
页码:1989 / 1995
页数:7
相关论文
共 53 条
  • [1] BELAID Y, 2005, NAT IMMUNOL, V6, P353
  • [2] Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations
    Bess, JW
    Gorelick, RJ
    Bosche, WJ
    Henderson, LE
    Arthur, LO
    [J]. VIROLOGY, 1997, 230 (01) : 134 - 144
  • [3] CAMERON PU, 1992, CLIN EXP IMMUNOL, V88, P226, DOI 10.1111/j.1365-2249.1992.tb03066.x
  • [4] Persistent decreases in blood plasmacytoid dendritic cell number and function despite effective highly active antiretroviral therapy and increased blood myeloid dendritic cells in HIV-infected individuals
    Chehimi, J
    Campbell, DE
    Azzoni, L
    Bacheller, D
    Papasavvas, E
    Jerandi, G
    Mounzer, K
    Kostman, J
    Trinchieri, G
    Montaner, LJ
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (09) : 4796 - 4801
  • [5] Sites, mechanism of action and lack of reversibility of primate lentivirus inactivation by preferential covalent modification of virion internal proteins
    Chertova, E
    Crise, BJ
    Morcock, DR
    Bess, JW
    Henderson, LE
    Lifson, JD
    [J]. CURRENT MOLECULAR MEDICINE, 2003, 3 (03) : 265 - 272
  • [6] Envelope glycoprotein incorporation, not shedding of surface envelope glycoprotein (gp120/SU), is the primary determinant of SU content of purified human immunodeficiency virus type 1 and simian immunodeficiency virus
    Chertova, E
    Bess, JW
    Crise, BJ
    Sowder, RC
    Schaden, TM
    Hilburn, JM
    Hoxie, JA
    Benveniste, RE
    Lifson, JD
    Henderson, LE
    Arthur, LO
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (11) : 5315 - 5325
  • [7] CHIRMULE N, 1995, J IMMUNOL, V155, P917
  • [8] Chougnet C, 1998, EUR J IMMUNOL, V28, P646, DOI 10.1002/(SICI)1521-4141(199802)28:02<646::AID-IMMU646>3.0.CO
  • [9] 2-6
  • [10] Role of CD40 Ligand dysregulation in HIV-associated dysfunction of antigen-presenting cells
    Chougnet, C
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 2003, 74 (05) : 702 - 709